Author Parnetti, Lucilla

• 2012 | Review
  ​ ​Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update​
  del Campo, M.; Mollenhauer, B.; Bertolotto, A.; Engelborghs, S.; Hampel, H.; Simonsen, A. H.& Kapaki, E. et al.​ (2012)
  Biomarkers in Medicine, 6​(4) pp. 419​-430​.​
  Future Medicine Ltd. DOI: https://doi.org/10.2217/BMM.12.46 
  ​Details  DOI  PMID  PMC  WoS 

• 2012 | Journal Article | Research Paper
  ​ ​Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS​
  Otto, M.; Bowser, R.; Turner, M.; Berry, J.; Brettschneider, J.; Connor, J. & Costa, J. et al.​ (2012) 
  Amyotrophic Lateral Sclerosis, 13(1) pp. 1​-10​.​ DOI: https://doi.org/10.3109/17482968.2011.627589 
  ​Details  DOI  PMID  PMC 

• 2012 | Journal Article | 
  ​ ​Differential Sialylation of Serpin A1 in the Early Diagnosis of Parkinson’s Disease Dementia​
  Jesse, S.; Lehnert, S.; Jahn, O.; Parnetti, L.; Soininen, H.; Herukka, S.-K. & Steinacker, P. et al.​ (2012) 
  PLoS ONE, 7(11) art. e48783​.​ DOI: https://doi.org/10.1371/journal.pone.0048783 
  ​Details  DOI 

• 2015 | Journal Article
  ​ ​Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly​
  Marizzoni, M.; Antelmi, L.; Bosch, B.; Bartrés-Faz, D.; Müller, B. W.; Wiltfang, J.   & Fiedler, U. et al.​ (2015) 
  Human Brain Mapping, 36(9) pp. 3516​-3527​.​ DOI: https://doi.org/10.1002/hbm.22859 
  ​Details  DOI 

• 2015 | Journal Article
  ​ ​Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study​
  Kruse, N.; Persson, S.; Alcolea, D.; Bahl, J. M. C.; Baldeiras, I.; Capello, E. & Chiasserini, D. et al.​ (2015) 
  Neurobiology of Aging, 36(9) pp. 2587​-2596​.​ DOI: https://doi.org/10.1016/j.neurobiolaging.2015.05.003 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article | 
  ​ ​The central biobank and virtual biobank of BiOMarKaPD: a resource for studies on neurodegenerative diseases​
  Reijs, B. L. R.; Teunissen, C. E.; Goncharenko, N.; Betsou, F.; Blennow, K.; Baldeiras, I. & Brosseron, F. et al.​ (2015) 
  Frontiers in Neurology, 6 art. UNSP 216​.​ DOI: https://doi.org/10.3389/fneur.2015.00216 
  ​Details  DOI  PMID  PMC  WoS 

• 2016 | Journal Article
  ​ ​Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques​
  Marchitelli, R.; Minati, L.; Marizzoni, M.; Bosch, B.; Bartrés-Faz, D.; Müller, B. W. & Wiltfang, J.  et al.​ (2016) 
  Human Brain Mapping, 37(6) pp. 2114​-2132​.​ DOI: https://doi.org/10.1002/hbm.23157 
  ​Details  DOI 

• 2016 | Journal Article
  ​ ​Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics​
  Lelental, N.; Brandner, S.; Kofanova, O.; Blennow, K.; Zetterberg, H.; Andreasson, U. & Engelborghs, S. et al.​ (2016) 
  Journal of Alzheimer's Disease, 52(1) pp. 51​-64​.​ DOI: https://doi.org/10.3233/jad-150883 
  ​Details  DOI 

• 2016 | Journal Article
  ​ ​Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a \‘European ADNI study’​
  Galluzzi, S.; Marizzoni, M.; Babiloni, C.; Albani, D.; Antelmi, L.; Bagnoli, C. & Bartrés-Faz, D. et al.​ (2016) 
  Journal of Internal Medicine, 279(6) pp. 576​-591​.​ DOI: https://doi.org/10.1111/joim.12482 
  ​Details  DOI 

• 2016 | Journal Article
  ​ ​Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects​
  Albi, A.; Pasternak, O.; Minati, L.; Marizzoni, M.; Bartrés-Faz, D.; Bargalló, N. & Bosch, B. et al.​ (2016) 
  Human Brain Mapping, 38(1) pp. 12​-26​.​ DOI: https://doi.org/10.1002/hbm.23350 
  ​Details  DOI 

• 2016 | Review
  ​ ​Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders​
  Mollenhauer, B.; Parnetti, L.; Rektorova, I.; Kramberger, M. G.; Pikkarainen, M.; Schulz-Schaeffer, W. J.& Aarsland, D. et al.​ (2016)
  Journal of Neurochemistry, 139​ pp. 290​-317​.​
  Wiley-blackwell. DOI: https://doi.org/10.1111/jnc.13390 
  ​Details  DOI  PMID  PMC  WoS 

• 2016 | Journal Article
  ​ ​The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature​
  Simonsen, A. H.; Kuiperij, B.; El-Agnaf, O. M. A.; Engelborghs, S.; Herukka, S.-K.; Parnetti, L. & Rektorova, I. et al.​ (2016) 
  Biomarkers in Medicine, 10(1) pp. 19​-34​.​ DOI: https://doi.org/10.2217/BMM.14.105 
  ​Details  DOI  PMID  PMC  WoS 

• 2017 | Journal Article
  ​ ​Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI)​
  Nathan, P. J.; Lim, Y. Y.; Abbott, R.; Galluzzi, S.; Marizzoni, M.; Babiloni, C. & Albani, D. et al.​ (2017) 
  Neurobiology of Aging, 53 pp. 1​-10​.​ DOI: https://doi.org/10.1016/j.neurobiolaging.2017.01.013 
  ​Details  DOI 

• 2017 | Journal Article | 
  ​ ​Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia​
  Chiasserini, D.; Biscetti, L.; Eusebi, P.; Salvadori, N.; Frattini, G.; Simoni, S. & De Roeck, N. et al.​ (2017) 
  Alzheimer's Research & Therapy, 9(1).​ DOI: https://doi.org/10.1186/s13195-017-0276-4 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry​
  Lewczuk, P. ; Riederer, P.; O’Bryant, S. E.; Verbeek, M. M.; Dubois, B.; Visser, P. J. & Jellinger, K. A. et al.​ (2018) 
  The World Journal of Biological Psychiatry, 19(4) pp. 244​-328​.​ DOI: https://doi.org/10.1080/15622975.2017.1375556 
  ​Details  DOI 

• 2018 | Journal Article | 
  ​ ​White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation​
  Teunissen, C. E.; Otto, M. ; Engelborghs, S.; Herukka, S.-K.; Lehmann, S.; Lewczuk, P.   & Lleó, A. et al.​ (2018) 
  Alzheimer's Research & Therapy, 10(1).​ DOI: https://doi.org/10.1186/s13195-018-0359-x 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer’s Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity​
  Jovicich, J.; Babiloni, C.; Ferrari, C.; Marizzoni, M.; Moretti, D. V.; Del Percio, C. & Lizio, R. et al.​ (2019) 
  Journal of Alzheimer's Disease, 69(1) pp. 15​-35​.​ DOI: https://doi.org/10.3233/JAD-180158 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​Plasma Aβ42 as a Biomarker of Prodromal Alzheimer’s Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study​
  Albani, D.; Marizzoni, M.; Ferrari, C.; Fusco, F.; Boeri, L.; Raimondi, I. & Jovicich, J. et al.​ (2019) 
  Journal of Alzheimer's Disease, 69(1) pp. 37​-48​.​ DOI: https://doi.org/10.3233/JAD-180321 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer’s Disease​
  Marizzoni, M.; Ferrari, C.; Macis, A.; Jovicich, J.; Albani, D.; Babiloni, C. & Cavaliere, L. et al.​ (2019) 
  Journal of Alzheimer's Disease, 69(1) pp. 49​-58​.​ DOI: https://doi.org/10.3233/JAD-181016 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​Has the time arrived for cerebrospinal fluid biomarkers in psychiatric disorders?​
  Lleó, A.; Parnetti, L.; Belbin, O. & Wiltfang, J. ​ (2019) 
  Clinica Chimica Acta, 491 pp. 81​-84​.​ DOI: https://doi.org/10.1016/j.cca.2019.01.019 
  ​Details  DOI 

Researcher

Sort

Items per Page